Market Research Logo

Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review

Perrigo Company Plc (PRGO) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutical ingredients (APIs) and infant formulas. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drug, supermarket and mass merchandise chains and direct sales representatives. The company has operations in North America, Europe, Australia and other countries including Israel and China. Perrigo is headquartered in Dublin, Ireland.

Perrigo Company Plc Key Recent Developments

Mar 01,2018: Perrigo Company Reports Fourth Quarter & Calendar Year 2017 Financial Results
Feb 27,2018: Perrigo Company Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results
Feb 20,2018: Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer
Jan 08,2018: Perrigo Appoints Uwe Rohrhoff As President & Chief Executive Officer
Nov 09,2017: Perrigo Company Reports Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Perrigo Company Plc - Key Facts
Perrigo Company Plc - Key Employees
Perrigo Company Plc - Key Employee Biographies
Perrigo Company Plc - Major Products and Services
Perrigo Company Plc - History
Perrigo Company Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Perrigo Company Plc - Business Description
Business Segment: CHCA Segment
Overview
Performance
Business Segment: CHCI Segment
Overview
Performance
Business Segment: Rx Pharmaceuticals Segment
Overview
Performance
Geographical Segment: All Other Countries
Target Markets
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Ireland
Performance
Geographical Segment: US
Performance
Perrigo Company Plc - Corporate Strategy
Perrigo Company Plc - SWOT Analysis
SWOT Analysis - Overview
Perrigo Company Plc - Strengths
Perrigo Company Plc - Weaknesses
Perrigo Company Plc - Opportunities
Perrigo Company Plc - Threats
Perrigo Company Plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Perrigo Company Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 01, 2018: Perrigo Company Reports Fourth Quarter & Calendar Year 2017 Financial Results
Feb 27, 2018: Perrigo Company Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results
Feb 20, 2018: Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer
Jan 08, 2018: Perrigo Appoints Uwe Rohrhoff As President & Chief Executive Officer
Nov 09, 2017: Perrigo Company Reports Third Quarter 2017 Financial Results
Aug 10, 2017: Perrigo Company Reports Second Quarter 2017 Financial Results
Jun 21, 2017: Perrigo Announces the Launch of Generic Equivalents to Derma-Smoothe/FS Scalp Oil and Body Oil
Jun 05, 2017: Perrigo Announces Forthcoming Retirement Of CEO John Hendrickson
May 30, 2017: Perrigo Company Files First Quarter 2017 Form 10-Q And Reports First Quarter 2017 Financial Results
May 22, 2017: Perrigo Reports Fourth Quarter
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Perrigo Company Plc, Key Facts
Perrigo Company Plc, Key Employees
Perrigo Company Plc, Key Employee Biographies
Perrigo Company Plc, Major Products and Services
Perrigo Company Plc, History
Perrigo Company Plc, Subsidiaries
Perrigo Company Plc, Key Competitors
Perrigo Company Plc, Ratios based on current share price
Perrigo Company Plc, Annual Ratios
Perrigo Company Plc, Annual Ratios (Cont...1)
Perrigo Company Plc, Annual Ratios (Cont...2)
Perrigo Company Plc, Interim Ratios
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Perrigo Company Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Perrigo Company Plc, Performance Chart (2013 - 2017)
Perrigo Company Plc, Ratio Charts
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Perrigo Company Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report